Mabeus Dental - Marshfield, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 W Mcmillan St Ste 2a, Marshfield, WI 54449 Phone: 715-384-5444 Fax: 715-384-9019 |
Mabeus Dental Office, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 W. Mcmillan St, Suite 2a, Marshfield, WI 54449 Phone: 715-384-5444 Fax: 715-384-9019 |
Martin Dental Sc Dentist Medicare: Not Enrolled in Medicare Practice Location: 605 E 4th St, Marshfield, WI 54449 Phone: 715-387-6344 Fax: 715-384-2047 |
Mapleleaf Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 504 S Chestnut Ave, Marshfield, WI 54449 Phone: 715-384-3515 |
Family Health Center/marshfield Clinic Dental Centers Clinic/Center - Dental Medicare: Medicare Enrolled Practice Location: 1307 N Saint Joseph Ave, Marshfield, WI 54449 Phone: 715-221-5600 |
Prairie Run Dental S.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1807 Prairie Drive, Marshfield, WI 54449 Phone: 715-387-1724 Fax: 715-384-5310 |
Dental Clinic Of Marshfield Sc Dentist Medicare: Not Enrolled in Medicare Practice Location: 306 West Mcmillan Road, Marshfield, WI 54449 Phone: 715-387-1702 Fax: 715-387-8174 |
News Archive
A previously unknown multi-resistant bacterium has been sticking around at a Swedish University Hospital for ten years.
Fortimedix Surgical today announced the completion of an €11M Series A funding round.
The key to immune-based cancer therapies lies in the ability to exploit some weakness within the tumor and its environment or to elude cancer's offenses. Writing in the journal Scientific Reports, researchers led by a group from the Roswell Park Cancer Institute Center for Immunotherapy have shared new insights about a subset of T cells that appear to do both those things, inhibiting cancer growth at the same time that they enhance the tumor-killing powers of other immune cells.
UCB has announced that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Keppra (levetiracetam). The decision was based on pediatric data submitted to the FDA following a written request in 2001.
The first study of the effects of testosterone on mood, behavior and psychological health in men with mild Alzheimer disease finds significant improvements in quality of life, as assessed by caregivers.
› Verified 4 days ago